These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7102416)

  • 1. The pathophysiology of cerebral vasospasm, and pharmacological approaches to its management.
    Towart R
    Acta Neurochir (Wien); 1982; 63(1-4):253-8. PubMed ID: 7102416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology and principles of treatment of vasospasm].
    Melon E
    J Neuroradiol; 1999 Mar; 26(1 Suppl):S30-5. PubMed ID: 10363450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs.
    Takayasu M; Suzuki Y; Shibuya M; Asano T; Kanamori M; Okada T; Kageyama N; Hidaka H
    J Neurosurg; 1986 Jul; 65(1):80-5. PubMed ID: 3712031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action.
    Kazda S; Towart R
    Acta Neurochir (Wien); 1982; 63(1-4):259-65. PubMed ID: 7102417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral vasospasm. The cerebral arterial spasm of subarachnoid hemorrhage--a new hemodynamic dimension].
    Pendefunda L; Georgescu EM
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(4):649-54. PubMed ID: 3253916
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium blocking agents for treatment of cerebral vasospasm.
    Peck S
    J Neurosurg Nurs; 1983 Jun; 15(3):123-7. PubMed ID: 6553074
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium antagonists and vasospasm.
    Meyer FB
    Neurosurg Clin N Am; 1990 Apr; 1(2):367-76. PubMed ID: 2136149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Findlay JM; Macdonald RL; Weir BK
    Cerebrovasc Brain Metab Rev; 1991; 3(4):336-61. PubMed ID: 1772740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Kassell NF; Sasaki T; Colohan AR; Nazar G
    Stroke; 1985; 16(4):562-72. PubMed ID: 3895589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine).
    Voldby B; Petersen OF; Buhl M; Jakobsen P; Ostergaard R
    Acta Neurochir (Wien); 1984; 70(3-4):243-54. PubMed ID: 6546832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs.
    Shibuya M; Suzuki Y; Takayasu M; Asano T; Harada T; Ikegaki I; Satoh S; Hidaka H
    Acta Neurochir (Wien); 1988; 90(1-2):53-9. PubMed ID: 3344625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of cerebral vasospasm.
    Cook DA
    Pharmacology; 1984; 29(1):1-16. PubMed ID: 6379682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral vasospasm following subarachnoid hemorrhage. New aspects of diagnosis and therapy].
    Voth D
    Zentralbl Neurochir; 1987; 48(2):89-101. PubMed ID: 3314267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of vasospasm.
    Levati A; Solaini C; Boselli L
    J Neurosurg Sci; 1998 Mar; 42(1 Suppl 1):27-31. PubMed ID: 9800599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of vasospasm due to subarachnoid hemorrhage with calcium entry blockers.
    Przuntek H; von Baumgarten F; Mertens HG
    Eur Neurol; 1986; 25 Suppl 1():86-92. PubMed ID: 3530777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm].
    Nishizawa Y
    Nihon Rinsho; 1993 Dec; 51 Suppl():389-96. PubMed ID: 8121018
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebral vasospasm.
    Wilkins RH
    Crit Rev Neurobiol; 1990; 6(1):51-77. PubMed ID: 2225095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm.
    Gioia AE; White RP; Bakhtian B; Robertson JT
    J Neurosurg; 1985 May; 62(5):721-8. PubMed ID: 3838768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.